SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2018 / Cilt: 66 - Sayı: 1

Management of parapneumonic effusion in pregnant women

Gebe kadınlarda parapnömonik efüzyonun yönetimi

Öner DİKENSOY
Ebru DİKENSOY
Richard W. LİGHT
Pages
64–67
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The data on the management of PPE in pregnantwomen is limited to few case reports.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pneumonia and parapneumonic effusion (PPE) are not more common in pregnant women compared to normal population.Pneumonia is considered the second most common infection in pregnant women.
📊
Key Findings & Data:PPE is a serious complication of pneumonia andoccurs especially in case of treatment delay or inappropriate antibiotic selection.
💡
Conclusion & Impact:The data on the management of PPE in pregnantwomen is limited to few case reports.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pneumonia and parapneumonic effusion (PPE) are not more common in pregnant women compared to normal population.Pneumonia is considered the second most common infection in pregnant women. PPE is a serious complication of pneumonia andoccurs especially in case of treatment delay or inappropriate antibiotic selection. The data on the management of PPE in pregnantwomen is limited to few case reports.

Özet

Pnömoni ve parapnömonik efüzyon (PPE)'un görülme sıklığı gebe kadınlarda normal popülasyona kıyasla daha fazla değildir. Pnömoni gebe kadınlarda en sık ikinci infeksiyon olarak kabul edilir. PPE pnömoninin önemli bir komplikasyonudur ve özellikle tedavinin geciktiği veya antibiyotiğin uygun seçilmediği olgularda görülür. Gebe kadınlarda PPE yönetimi konusundaki veriler bir kaç olgu sunumu ile kısıtlıdır.

🔖

Cite This Article

DİKENSOY, Ö., DİKENSOY, E., LİGHT, R. W. (2022). Management of parapneumonic effusion in pregnant women. Tüberküloz ve Toraks, Cilt: 66 - Sayı: 1, 64–67. https://ajindex.com/articles/618443

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Curr Opin Infect Dis. 2018.
  2. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-71.
  3. Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989; 161:657-62.
  4. Munn MB, Groome LJ, Atterbury JL, Baker SL, Hoff C. Pneumonia as a complication of pregnancy. J Matern Fetal Med 1999; 8:151-4.
  5. Heffner, JE, McDonald, J, Barbieri, C, Klein J. Management of parapneumonic effusion. Arch Surg 1995;130:433-8.
  6. Strange, C Sahn, SA. The clinician’s perspective on parapneumonic effusion and empyema. Chest.1993;103:259-261. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80.
  7. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33(10 Suppl):S390-7 Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW. Antibiotic levels in empyemic pleural fluid. Chest 2000;117(6):1734-9.
  8. Liapakis IE, Light RW, Pitiakoudis MS, Karayiannakis AJ, Giamarellos-Bourboulis EJ, Ismailos G, et al. Penetration of clarithromycin in experimental pleural empyema model fluid. Respiration 2005;72:296-300. FDA/CDER SBIA Chronicles. Drugs in Pregnancy and Lactation: Improved Benefit-Risk Information. January 22, 2015. Accessed July 25, 2016 at http://www.fda.gov/ downloads/Drugs/DevelopmentApprovalProcess/ SmallBusinessAssistance/UCM431132.pdf Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658-60.
  9. Ulutas H, Yekeler E, Ali Sak ZH, Doru I, Kuzucu A. Fibrinolytic therapy for parapneumonic empyema during pregnancy. Respiratory Medicine Case Reports. 2012;5:55-8.
  10. Torbic H, Inaty H, Raja S, Choi H. Safe administration of intrapleural alteplase during pregnancy. J Thorac Dis 2017;9:E801-E804. Sousa Gomes M, Guimarães M, Montenegro N. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med 2018;29:1-331.
  11. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 2011;9:107. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab